Synthetic Biomaterial Compound

Covers claims enabling systems and methods describing the molecular and chemical properties of a compound for uses in various bone-related clinical conditions


Asset List

US Patent No. 6,585,992
US Patent No. 6,323,146
RE 41,251 (of ‘146 patent)
US Patent No. 6,846,493
US Application No. 1/738,052


Portfolio Summary

This portfolio is directed to a synthetic biomaterial compound based on stabilized calcium phosphates and to the molecular, structural and physical characterization of this compound. The knowledge of the molecular and chemical properties of the compound allows for uses of the compound in various bone-related clinical conditions